Clinical trial on management of acidity and indigestio
Phase 3
- Conditions
- Health Condition 1: K30- Functional dyspepsia
- Registration Number
- CTRI/2022/01/039167
- Lead Sponsor
- Tejaswini Khachane
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Cases covering the case definition will be considered in my study.
2.Patient having symptoms like heartburn, abdominal bloating, abdominal discomfort, flatulence, pain in abdomen after eating.
3.Cases presenting with symptoms of functional dyspepsia with no pathology.
Exclusion Criteria
1.Cases having systemic illness.
2.Patient suffering from life threatening diseases
3.Advance pathology like Ca, intestinal obstruction
4.Patients who require emergency medical treatment.
5.Pregnant and lactating woman.
6.Patients who are not willing to sign the consent form.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To determine the improvement in the functional dyspepsia before and after treatment. <br/ ><br>2.To determine the effectiveness of Pulsatilla in functional dyspepsia.Timepoint: 1.Effectiveness of Pulsatilla on functional dyspepsia is determine with the follow up taken every 3-7 days after medicine prescribed for 2 months.
- Secondary Outcome Measures
Name Time Method To study the effects of alkaloids of Pulsatilla in management of functional dyspepsiaTimepoint: All the patients are duly followed up it may be differ from patient to patient and taken as per need of case